Proteomic analysis of phosphorylation in cancer

Expert Review of Proteomics

Volumn 11, Issue 3, 2014, Pages 259-267

  Ruprecht, Benjamin ^a,b   Lemeer, Simone ^a,b,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Munich Center for Integrated Protein Science   (Germany)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

cancer research; clinical phosphoproteomics; phosphopeptide enrichment; phosphorylation; proteomics; signaling

Indexed keywords

DIGLYCINE; FERROUS ION; NITRILOTRIACETIC ACID; PHOSPHOPEPTIDE; PHOSPHOTYROSINE; THREONINE; TYROSINE; PHOSPHOPROTEIN; PROTEOME;

AFFINITY CHROMATOGRAPHY; ANTIBODY AFFINITY; ARTICLE; BIOINFORMATICS; CANCER CELL LINE; CANCER RESEARCH; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTIONATION; HUMAN; ION MONITORING; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; PH; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; METABOLISM; NEOPLASM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

HUMANS; NEOPLASMS; PHOSPHOPEPTIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEOME; SIGNAL TRANSDUCTION;

EID: 84901065408     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.2014.901156     Document Type: Article

References (79)

1. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001;411(6835): 355-65
2. Weinstein IB, Joe AK. Mechanisms of Disease: oncogene addiction-a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol 2006;3(8):448-57
3. Sharma SV, Bell DW, Settleman J, Haber DA. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007;7(3):169-81
4. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235(4785):177-82
5. Walker-Daniels J, Coffman K, Azimi M, et al. Overexpression of the EphA2 tyrosine kinase in prostate cancer. Prostate 1999; 41(4):275-80
6. Lutz MP, Esser IB, Flossmann-Kast BB, et al. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun 1998;243(2):503-8
7. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417(6892):949-54
8. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344(14):1031-7
9. Lemeer S, Heck AJ. The phosphoproteomics data explosion. Curr Opin Chem Biol 2009;13(4):414-20
10. Andersson L, Porath J. Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography. Anal Biochem 1986;154(1):250-4
11. Posewitz MC, Tempst P. Immobilized gallium(III) affinity chromatography of phosphopeptides. Anal Chem 1999;71(14): 2883-92
12. Pinkse MW, Uitto PM, Hilhorst MJ, et al. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal Chem 2004;76(14):3935-43
13. McNulty DE, Annan RS. Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol Cell Proteomics 2008; 7(5):971-80
14. Oda Y, Nagasu T, Chait BT. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat Biotechnol 2001;19(4):379-82
15. Beausoleil SA, Jedrychowski M, Schwartz D, et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci USA 2004;101(33):12130-5
16. Nuhse TS, Stensballe A, Jensen ON, Peck SC. Large-scale analysis of in vivo phosphorylated membrane proteins by immobilized metal ion affinity chromatography and mass spectrometry. Mol Cell Proteomics 2003;2(11):1234-43
17. Dunn JD, Watson JT, Bruening ML. Detection of phosphopeptides using Fe(III)-nitrilotriacetate complexes immobilized on a MALDI plate. Anal Chem 2006;78(5): 1574-80
18. Ficarro SB, McCleland ML, Stukenberg PT, et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 2002;20(3):301-5
19. Larsen MR, Thingholm TE, Jensen ON, et al. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics 2005; 4(7):873-86
20. Thingholm TE, Jensen ON, Robinson PJ, Larsen MR. SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol Cell Proteomics 2008;7(4):661-71
21. Sugiyama N, Masuda T, Shinoda K, et al. Phosphopeptide enrichment by aliphatic hydroxy acid-modified metal oxide chromatography for nano-LC-MS/MS in proteomics applications. Mol Cell Proteomics 2007;6(6):1103-9
22. Zhou H, Ye M, Dong J, et al. Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis. J Proteome Res 2008;7(9):3957-67
23. Zhou H, Ye M, Dong J, et al. Robust phosphoproteome enrichment using monodisperse microsphere-based immobilized titanium (IV) ion affinity chromatography. Nat Protoc 2013;8(3): 461-80
24. Hennrich ML, van den Toorn HW, Groenewold V, et al. Ultra acidic strong cation exchange enabling the efficient enrichment of basic phosphopeptides. Anal Chem 2012;84(4):1804-8
25. Di Palma S, Zoumaro-Djayoon A, Peng M, et al. Finding the same needles in the haystack? A comparison of phosphotyrosine peptides enriched by immuno-affinity precipitation and metal-based affinity chromatography. J Proteomics 2013;91C: 331-7
26. Zhou H, Di Palma S, Preisinger C, et al. Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 2013;12(1):260-71
27. Engholm-Keller K, Birck P, Storling J, et al. TiSH-a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC. J Proteomics 2012;75(18):5749-61
28. Giansanti P, Stokes MP, Silva JC, et al. Interrogating cAMP-dependent kinase signaling in Jurkat T-Cells by a protein kinase A targeted immune-precipitation phosphoproteomics approach. Mol Cell Proteomics 2013;12(11):3350-9
29. Li QR, Ning ZB, Tang JS, et al. Effect of peptide-to-TiO2 beads ratio on phosphopeptide enrichment selectivity. J Proteome Res 2009;8(11):5375-81
30. Kettenbach AN, Gerber SA. Rapid and reproducible single-stage phosphopeptide enrichment of complex peptide mixtures: application to general and phosphotyrosine-specific phosphoproteomics experiments. Anal Chem 2011;83(20): 7635-44
31. Nilsson CL. Advances in quantitative phosphoproteomics. Anal Chem 2012; 84(2):735-46
32. Neilson KA, Ali NA, Muralidharan S, et al. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 2011;11(4):535-53
33. Kocher T, Pichler P, Swart R, Mechtler K. Analysis of protein mixtures from whole-cell extracts by single-run nanoLC-MS/MS using ultralong gradients. Nat Protoc 2012; 7(5):882-90
34. Gnad F, Young A, Zhou W, et al. Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomics. Mol Cell Proteomics 2013;12(8):2070-80
35. Courcelles M, Fremin C, Voisin L, et al. Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions. Mol Syst Biol 2013;9:669
36. Brill LM, Salomon AR, Ficarro SB, et al. Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal Chem 2004;76(10): 2763-72
37. Salomon AR, Ficarro SB, Brill LM, et al. Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc Natl Acad Sci USA 2003; 100(2):443-8
38. Tinti M, Nardozza AP, Ferrari E, et al. The 4G10, pY20 and p-TYR-100 antibody specificity: profiling by peptide microarrays. New Biotechnol 2012;29(5):571-7
39. Moritz A, Li Y, Guo A, et al. Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal 2010;3(136):ra64
40. Matsuoka S, Ballif BA, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007;316(5828): 1160-6
41. Lange V, Picotti P, Domon B, Aebersold R Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 2008;4:222
42. Collins BC, Gillet LC, Rosenberger G, et al. Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system. Nat Methods 2013;10(12):1246-53
43. Gallien S, Duriez E, Crone C, et al. Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol Cell Proteomics 2012;11(12):1709-23
44. Sharma SV, Haber DA, Settleman J. Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nat Rev Cancer 2010;10(4):241-53
45. Gholami AM, Hahne H, Wu ZX, et al. Global proteome analysis of the NCI-60 cell line panel. Cell Rep 2013;4(3):609-20
46. Miller ML, Molinelli EJ, Nair JS, et al. Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets. Sci Signal 2013;6(294):ra85
47. Kirouac DC, Du JY, Lahdenranta J, et al. Computational modeling of ERBB2-amplified breast cancer identifies combined erbb2/3 blockade as superior to the combination of MEK and AKT inhibitors. Sci Signal 2013;6(288):ra68
48. Zheng Y, Zhang CJ, Croucher DR, et al. Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature 2013;499(7457):166-71
49. Hennrich ML, Marino F, Groenewold V, et al. Universal quantitative kinase assay based on diagonal SCX chromatography and stable isotope dimethyl labeling provides high-definition kinase consensus motifs for PKA and human Mps1. J Proteome Res 2013;12(5):2214-24
50. Xue L, Geahlen RL, Tao WA. Identification of direct tyrosine kinase substrates based on protein kinase assay-linked phosphoproteomics. Mol Cell Proteomics 2013;12(10):2969-80
51. Xue L, Wang WH, Iliuk A, et al. Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates. Proc Natl Acad Sci USA 2012;109(15):5615-20
52. Casado P, Rodriguez-Prados JC, Cosulich SC, et al. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal 2013; 6(268):rs6
53. Chong CR, Janne PA. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med 2013;19(11): 1389-400
54. Rexer BN, Ham AJL, Rinehart C, et al. Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Oncogene 2011;30(40):4163-74
55. Gioia R, Leroy C, Drullion C, et al. Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells. Blood 2011;118(8):2211-21
56. Rubbi L, Titz B, Brown L, et al. Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling. Sci Signal 2011; 4(166):ra18
57. Geiger T, Madden SF, Gallagher WM, et al. Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res 2012;72(9): 2428-39
58. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490(7418):61-70
59. Clinical Lung Cancer Genome Project (CLCGP); Network Genomic Medicine (NGM). A genomics-based classification of human lung tumors. Sci Transl Med 2013; 5(209):209ra153
60. Wistuba II, Gelovani JG, Jacoby JJ, et al. Methodological and practical challenges for personalized cancer therapies. Nat Rev Clin Oncol 2011;8(3):135-41
61. Klammer M, Kaminski M, Zedler A, et al. Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11(9):651-68
62. Schweppe DK, Rigas JR, Gerber SA. Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 2013;91:286-96
63. Zhang H, Pelech S. Using protein microarrays to study phosphorylation-mediated signal transduction. Semin Cell Dev Biol 2012; 23(8):872-82
64. Narumi R, Murakami T, Kuga T, et al. A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res 2012; 11(11):5311-22
65. Beausoleil SA, Villén J, Gerber SA, et al. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 2006;24(10):1285-92
66. Taus T, Köcher T, Pichler P, et al. Universal and confident phosphorylation site localization using phosphoRS. J Proteome Res 2011;10(12):5354-62
67. Savitski MM, Lemeer S, Boesche M, et al. Confident phosphorylation site localization using the Mascot Delta Score. Mol Cell Proteomics 2011;10(2):M110.003830
68. Olsen JV, Blagoev B, Gnad F, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006; 127(3):635-48
69. Schwartz D, Gygi SP. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol 2005;23(11):1391-8
70. Obenauer JC, Cantley LC, Yaffe MB. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 2003; 31(13):3635-41
71. Yaffe M, Leparc G, Lai J, et al. A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol 2001;19(4): 348-53
72. Gnad F, Ren S, Cox J, et al. PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol 2007;8(11): R250
73. Gnad F, Gunawardena J, Mann M. PHOSIDA 2011: the posttranslational modification database. Nucleic Acids Res 2011;39:D253-60
74. Miller M, Jensen L, Diella F, et al. Linear motif atlas for phosphorylation-dependent signaling. Sci Signal 2008;1(35):ra2
75. Linding R, Jensen L, Pasculescu A, et al. NetworKIN: a resource for exploring cellular phosphorylation networks. Nucleic Acids Res 2008;36:D695-9
76. Diella F, Cameron S, Gemund C, et al. Phospho.ELM: A database of experimentally verified phosphorylation sites in eukaryotic proteins. BMC Bioinformatics 2004(5):79
77. Diella F, Gould C, Chica C, et al. Phospho.ELM: a database of phosphorylation sites-update 2008. Nucleic Acids Res 2008;36:D240-4
78. Dinkel H, Chica C, Via A, et al. Phospho. ELM: a database of phosphorylation sites-update 2011. Nucleic Acids Res 2011;39:D261-7
79. Hornbeck P, Kornhauser J, Tkachev S, et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 2012;40(D1): D261-70